Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What do LLMs value? An evaluation framework for revealing subjective trade-offs in assessment of glycemic control.

Proceedings of machine learning research·2026
Same author

Artificial intelligence for interpreting diabetes data using clinician-curated benchmarks.

The lancet. Diabetes & endocrinology·2026
Same author

Impact of continuous glucose monitoring on glycaemic risk index in adults with type 1 diabetes using multiple daily insulin injections in the GOLD trial.

Frontiers in clinical diabetes and healthcare·2026
Same author

Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.

Journal of diabetes science and technology·2026
Same author

Integrating trust into artificial intelligence for medicine: using diabetes as the exemplar disease.

Journal of translational medicine·2026
Same author

Modifiable Factors Affecting the Postprandial Glycemic Response.

Journal of diabetes science and technology·2026

Related Experiment Video

Updated: Jul 4, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

MetaboNet-Bench: A Multi-modal Benchmark for Glucose Forecasting in Type 1 Diabetes.

Nathaniel Jeffries1, Miriam Wolff2, Sam Royston2

  • 1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.

Arxiv
|July 3, 2026
PubMed
Summary

MetaboNet-Bench standardizes multimodal glucose forecasting for type 1 diabetes, enabling better algorithm comparison. Incorporating insulin and carbohydrate data improves forecasting, especially with complex models.

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Related Experiment Videos

Last Updated: Jul 4, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Endocrinology

Background:

  • Glucose forecasting is crucial for type 1 diabetes management.
  • Existing algorithms lack standardized evaluation, hindering progress.
  • Many models use only continuous glucose monitoring (CGM) data, ignoring other vital signals.

Purpose of the Study:

  • Introduce MetaboNet-Bench, an open-source framework for multimodal glucose forecasting.
  • Provide a standardized benchmark for evaluating algorithms using glucose, insulin, and carbohydrate data.
  • Facilitate fair comparison and drive innovation in type 1 diabetes glucose forecasting.

Main Methods:

  • Developed an extensible, open-source evaluation framework: MetaboNet-Bench.
  • Benchmarked several published glucose forecasting models and a custom multimodal model.
  • Utilized multimodal data including glucose, insulin, and carbohydrate intake.

Main Results:

  • Demonstrated the utility of MetaboNet-Bench for multimodal glucose forecasting.
  • Showcased that the benefit of additional data modalities depends on model complexity.
  • Highlighted that incorporating more clinical metrics aids in identifying research gaps.

Conclusions:

  • MetaboNet-Bench offers a standardized approach to multimodal glucose forecasting evaluation.
  • Multimodal data integration enhances forecasting accuracy, particularly for complex models.
  • This benchmark facilitates targeted future research in type 1 diabetes glycemic control.